Price Alert

Nanobiotix S.A. (NBTX)

NASDAQ: NBTX · Real-Time Price · USD

9.16

0.78 (9.31%)

At close: Aug 27, 2025, 3:59 PM

8.99

-1.86%

Pre-market: Aug 28, 2025, 05:26 AM EDT

Nanobiotix S.A. Statistics

Share Statistics

Nanobiotix S.A. has 47.3M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	47.3M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	12.19%
Shares Floating	37.83M
Failed to Deliver (FTD) Shares	219
FTD / Avg. Volume	2.21%

Short Selling Information

The latest short interest is 18.9K, so 0.04% of the outstanding shares have been sold short.

Short Interest	18.9K
Short % of Shares Out	0.04%
Short % of Float	0.05%
Short Ratio (days to cover)	2.29

Valuation Ratios

The PE ratio is -1.92 and the forward PE ratio is 58.07. Nanobiotix S.A.'s PEG ratio is -0.06.

PE Ratio	-1.92
Forward PE	58.07
PS Ratio	-11.28
Forward PS	4.6
PB Ratio	-1.99
P/FCF Ratio	-6.42
PEG Ratio	-0.06

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Nanobiotix S.A..

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of -0.77.

Current Ratio	1.04
Quick Ratio	1.04
Debt / Equity	-0.77
Debt / EBITDA	-0.87
Debt / FCF	-2.5
Interest Coverage	-8.46

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$-107.49K
Profits Per Employee	$-630.85K
Employee Count	108
Asset Turnover	-0.17
Inventory Turnover	n/a

Taxes

Income Tax	101K
Effective Tax Rate	-0.15%

Stock Price Statistics

The stock price has increased by 57.93% in the last 52 weeks. The beta is 1.5, so Nanobiotix S.A.'s price volatility has been higher than the market average.

Beta	1.5
52-Week Price Change	57.93%
50-Day Moving Average	6.36
200-Day Moving Average	4.25
Relative Strength Index (RSI)	60.96
Average Volume (20 Days)	9,904

Income Statement

In the last 12 months, Nanobiotix S.A. had revenue of -11.61M and earned -68.13M in profits. Earnings per share was -1.44.

Revenue	-11.61M
Gross Profit	-11.61M
Operating Income	-68.39M
Net Income	-68.13M
EBITDA	-58.32M
EBIT	-59.95M
Earnings Per Share (EPS)	-1.44

Full Income Statement

Balance Sheet

The company has 49.74M in cash and 50.9M in debt, giving a net cash position of -1.17M.

Cash & Cash Equivalents	49.74M
Total Debt	50.9M
Net Cash	-1.17M
Retained Earnings	-68.13M
Total Assets	67.42M
Working Capital	2.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.55M and capital expenditures -848K, giving a free cash flow of -20.4M.

Operating Cash Flow	-19.55M
Capital Expenditures	-848K
Free Cash Flow	-20.4M
FCF Per Share	-0.43

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of 589.13% and 586.89%.

Gross Margin	100%
Operating Margin	589.13%
Pretax Margin	586.02%
Profit Margin	586.89%
EBITDA Margin	502.4%
EBIT Margin	589.13%
FCF Margin	175.72%

Dividends & Yields

NBTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for NBTX is $8, which is -12.7% lower than the current price. The consensus rating is "Buy".

Price Target	$8
Price Target Difference	-12.7%
Analyst Consensus	Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-3.53
Piotroski F-Score	4